Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human…
Cardiotossicità da anti-HER2
-
-
Cardiac risk in the treatment of breast cancer: assessment and management Antonis Valachis and Cecilia Nilsson Breast…
-
Risk of Cardiomyopathy in Breast Cancer: How Can We Attenuate the Risk of Heart Failure…
-
Doxorubicin-induced heart failure in cancer patients: A cohort study based on the Korean National Health…
-
Evaluation and management of chemotherapy-induced cardiotoxicity in breast cancer: a Delphi study Gavila J, Seguí MÁ, Calvo…
-
Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A Population-Based…